777
Views
42
CrossRef citations to date
0
Altmetric
Review

Heart disease as a risk factor for dementia

, &
Pages 135-145 | Published online: 26 Apr 2013

Abstract

As life expectancy lengthens, dementia is becoming a significant human condition in terms of its prevalence and cost to society worldwide. It is important in that context to understand the preventable and treatable causes of dementia. This article exposes the link between dementia and heart disease in all its forms, including coronary artery disease, myocardial infarction, atrial fibrillation, valvular disease, and heart failure. This article also explores the cardiovascular risk factors and emphasizes that several of them are preventable and treatable. In addition to medical therapies, the lifestyle changes that may be useful in retarding the onset of dementia are also summarized.

Introduction

Dementia is a common neurological disorder and is an increasingly prevalent problem, especially among the elderly population. It is estimated there are upwards of 24.3 million cases of dementia presently, with that number expected to double every 20 years, resulting in 81.1 million cases in 2040.Citation1 The frequency of dementia is compounded by the growing worldwide population of the elderly (>65 years old), which is estimated to increase (from 606 million in 2000) to nearly 2 billion in 2050.Citation2

Dementia is a loss of brain function and overall global cognitive ability. It is the result of progressive impairment in more than one cognitive domain, leading to an eventual loss of the ability to perform all tasks of daily living.Citation3 Types of dementia include Alzheimer’s disease (AD), vascular dementia (VaD), frontotemporal dementia, dementia with Lewy body, Parkinson’s disease-related dementia, and dementia as a result of disease (for example AIDS or multiple sclerosis).Citation4 Cognitive impairment is a broad term that generally describes a decline in cognitive functions, and the severity of the impairment ranges from mild cognitive impairment (MCI) to dementia.

When investigating the effects of cognitive decline, many studies use MCI as the main outcome, instead of dementia. It is very important to note that while MCI is only considered an intermediate stage between a normal cognitive state and dementia, individuals with MCI are at an increased risk of progression to dementia, especially in the elderly.Citation5,Citation6 Multi-domain MCI, amnestic MCI (aMCI), and non-amnestic MCI (naMCI) all progress to different types of dementia, with the estimated annual progression rates of 12.2%, 11.7%, and 4.1%, respectively.Citation7 Therefore, even though dementia may evolve from MCI, the increased risk of progression means that it is still important to discuss studies whose main outcome is MCI, as we have done here. By contrast, while the presence of the APOE e4 allele is strongly associated with cardiovascular disease as well as cognitive impairment and dementia, it will not be discussed in detail in this review.

Heart disease is defined as any condition that impairs cardiac function regardless of the specific modality that is affected. Heart disease is a growing problem, and the resultant vascular insufficiency has the potential to impair function in other organs, including the brain.Citation8 There is an expanding body of literature implicating heart disease as a risk factor for dementia. In addition, a number of studies suggest that cardiovascular risk factors are independently associated with the development of dementia. These risk factors include hypertension, hypercholesterolemia, diabetes, obesity, and smoking. Even though there are many types of dementias and a wide spectrum of vascular cognitive impairment, this review will focus mainly on the two most common, AD and VaD,Citation9,Citation10 as well as the most common variety, mixed dementia that is characterized by multiple cerebral pathologies with prominent vascular involvement.Citation11 The purpose of this review is to present the current knowledge base regarding heart disease and its associated risk factors in relation to dementia.

Dementia

While it may not be surprising that heart disease is a significant cause of VaD, it is perhaps unexpected that more studies are also linking it to AD. VaD and AD have very different underlying pathologies. The pathology of AD is defined by the accumulation of neuritic plaques (β-amyloid (Aβ)) in the extracellular neuropil and neurofibrillary tangles (composed of tau protein) in neurons,Citation12 while VaD is characterized by a cerebrovascular pathology, exhibiting white matter hyperintensities, lacunar infarctions, and ischemic periventricular leukoencephalopathy.Citation13,Citation14 There is a large overlap between AD and VaD in regard to clinical features and neuropathological changes.Citation15 More specifically, both dementias can occur in tandem and share common cardiovascular risk factors which when clustered together can increase the likelihood of dementia independently or through the increased risk of heart disease.Citation16Citation20 For these reasons, a review by Bowler and Hachinski defined AD as a vascular disorder more than a decade ago.Citation21

Heart disease as a risk factor for dementia

Reduced cerebral blood flow(CBF) due to heart disease of any kind worsens the vascular homeostasis of the brain, and magnifies any cognitive problems caused by the buildup of tau and Aβ proteins. A recent study has shown that dementia patients with a prior history of heart disease are more likely to have structural and functional cardiac abnormalities compared with controls.Citation22 Using cardiac magnetic resonance imaging (MRI) as a method to measure cardiac function, this study has also shown that cardiac index, as a marker of overall cardiac function, is positively related to total brain volume and processing speed.Citation23 Positive associations have been shown between ischemic heart disease and cognitive impairment on the one hand, and between atherosclerotic cardiovascular disease and cognitive decline on the other.Citation24Citation26 As well, an association between the degeneration of myocardial post-ganglionic sympathetic nerves and the Lewy body variant in Parkinson’s disease has been reported.Citation27 It is important, however, to focus on more specific types of heart disease and dementia in order to clarify the relative contribution of each entity to cognitive impairment.

Coronary artery disease

The association between coronary artery disease and cognitive decline, including dementia, is strong. Atherosclerosis plays a major role in the development of both coronary artery disease and dementia. In the Cardiovascular Health Study cohort, the incidence of dementia was higher in those with prevalent coronary artery disease,Citation28 and several studies have confirmed that coronary artery disease is associated with cognitive impairment,Citation29Citation31 reduced hippocampal volume,Citation32 dementia due to platelet hyperactivity,Citation33 and increased senile plaque formation in cortical areas of the brain.Citation34 A recent study by Graban and colleagues showed that coronary artery disease was observed more frequently in VaD patients.Citation35 Cross-section analysis of the AGES-Reykjavik Study by Vidal and colleagues showed that lower scores on each cognitive domain were strongly related to atherosclerotic burden, indirectly estimated by coronary artery calcium (CAC) load. The percentage of dementia significantly increased with quartiles of CAC (Q1 10.3%, Q2 21.8%, Q3 29.1%, Q4 38.8%), while gray matter, white matter, and total brain tissue volumes decreased.Citation36

Coronary artery disease may lead to dementia through its association with brain small vessel disease.Citation37,Citation38 Small vessel disease in turn disturbs CBF regulation and perfusion, disrupts the blood–brain barrier, and leads to an increased susceptibility to neurological insults.Citation39 In addition, the failure in small vessel disease to clear excess Aβ produced by cortical neurons contributes to cerebral hemorrhaging and AD pathology.Citation40,Citation41

Atrial fibrillation (AF)

AF, the most common cardiac arrhythmia, is an important and modifiable cause of ischemic stroke and results in considerable physical and cognitive disability. While there is still some uncertainty regarding the relationship between AF and dementia in the absence of stroke,Citation42,Citation43 it is clear that AF can be considered a contributor to the onset of dementia.Citation44Citation47 Moreover, there is growing evidence supporting AF as a risk factor for dementia without stroke.Citation48Citation50

Recent data also show an association between AF and AD progression.Citation51 In a study of 37,025 patients, 10,161 (27%) developed AF and 1535 (4.1%) developed dementia, and AF was independently significantly associated with senile, vascular, and AD dementia.Citation52 The cross-sectional analysis in the Rotterdam study reported that AF exerts its effects only partly through stroke and showed a significant association between AF and both dementia and cognitive decline, where dementia was twice as common among AF patients than controls.Citation53 The strongest association was for AD with cerebrovascular disease, rather than VaD.Citation53 In a recent analysis of the ONTARGET and TRANSCEND studies by Marzona and colleagues, it was determined that AF was associated with an increased risk of cognitive decline (hazard ratio [HR] 1.14, 95% confidence interval [CI] 1.03–1.26) and new dementia (HR 1.14, 95% CI 1.14–1.49).Citation54 In another longitudinal, community-based cohort study by Miyasaka and colleagues, 299 AF subjects were diagnosed with dementia, with an estimated overall incidence rate of 22.5 per 1000 person-years, suggesting a risk of dementia following the development of AF.Citation55 Finally, studies show that AF is associated with brain abnormalities, more specifically, a smaller hippocampal volume and left ventricular hypertrophy.Citation56 In addition, in individuals suffering from AF, learning, memory, attention, and executive functions are poorer,Citation57 consistent with other studies showing decreased scores on cognitive domain tests in patients with AF.Citation58,Citation59

Several mechanisms have been suggested linking AF and dementia. In AF, irregular rapid ventricular rates could lead to decreased cerebral perfusion due to low cardiac output.Citation60Citation62 Another suggested mechanism is the increase in risk of covert cerebral infarction and transient ischemic attacks.Citation63Citation65 AF also leads to a hypercoagulable state, which may give rise to subclinical cerebral embolism.Citation66,Citation67 Finally, experimental data suggest that cerebrovascular disease may precipitate neurodegenerative changes seen as white matter hyperintensities on MRI.Citation68,Citation69

Myocardial infarction (MI)

There are a limited number of studies associating MI with dementia. Men with unrecognized MI have an increased risk of stroke.Citation70 Those with MI also share a genetic background with AD, involving abnormalities in cholesterol metabolism and an upregulation in inflammation. Some studies have reported that there is a higher risk of cognitive impairment after MI due to brain hypoperfusion,Citation71 and a cross-sectional evaluation in the Rotterdam study showed a positive association between cognitive impairment and prior MI.Citation72 In addition, the Bronx Aging Study showed that women with a history of MI had a fivefold increase in the risk of dementia.Citation73 Gharacholou and colleagues showed that older subjects with prior MI had measurable cognitive impairment prior to dementia.Citation74 Finally, using the results from the Rotterdam and Rotterdam Scan Study, Ikram and colleagues demonstrated that in men, unrecognized MI was associated with an increased risk of dementia (HR 2.14, 95% CI 1.37–3.35), increased white matter lesion load, and brain infarctions,Citation75 supporting the possibility that small vessel disease may be one mechanism by which the risk of dementia increases in MI patients.

However, the impact of MI on dementia remains controversial, and findings lack consistency.Citation76 Studies such as the Honolulu-Asia Aging Study found no association between MI and later cognitive impairment.Citation77 In a population-based study by Bursi and colleagues, the frequency of MI preceding dementia was identical in the index cases and the control subjects, thus showing no significant evidence of a positive association between MI and dementia.Citation78 Therefore, further research is needed to enhance our understanding of the influence of MI on subsequent dementia.

Valve disease

Studies have reported significant aortic and mitral valve disease in AD subjects compared with a non-demented control group at autopsy.Citation79 Boudoulas and colleagues concluded that left atrial dysfunction increased with chronic mitral valve disease, contributing to AF, thereby increasing risk of dementia.Citation80 This is supported by work done by Rodriguez and colleagues in a community-based study of 2680 participants from the Cardiovascular Health Study who underwent MRI analysis. Participants, without prior history of stroke, with left-sided annular or valvular calcification had a 33% greater risk of covert brain infarcts.Citation81 Coupled with other studies demonstrating the presence of brain infarcts in association with calcification of the aortic valve, this supports the association between valve disease and a higher risk of both stroke and cognitive decline.Citation82Citation84 Thus, evaluation of patients for aortic and mitral valve disease may be important in the work-up of dementia and its prevention.

Heart failure (HF)

HF is defined as insufficient cardiac pump function to provide adequate perfusion to body organs. HF is a growing problem with significant prevalence and mortality rates. In the elderly (>65 years of age), 6%–10% of the population has a diagnosis of HF.Citation85 Any number of underlying heart conditions and diseases can lead to HF, including those mentioned in previous sections. According to the Heart-Mind Study, participants with both HF and coronary artery disease were found to experience similar declines in cognitive function versus non-controls with HF but not coronary artery disease.Citation86

Studies have reported that HF is associated with both cognitive impairment and dementia.Citation87Citation92 In a recent pilot case-control study, HF patients had lower scores on a neuropsychological battery designed to assess cognitive functions for dementia than controls in visuospatial, executive function, visual memory, and verbal learning tasks, and showed structural brain changes including right medial temporal lobe atrophy.Citation93

The pathophysiological mechanisms that underlie the association between HF and cognitive impairment and dementia are still being investigated. Reduced CBF seems to worsen cognitive impairment associated with HF, and those with heart transplantation had a restoration of CBF and improved cognitive performance.Citation94Citation96 In HF, low cardiac output combined with impaired cerebral autoregulatory mechanisms, may result in decreased CBF leading to the association with cognitive impairment and dementia.Citation23,Citation97,Citation98 HF is also a risk factor for multiple cerebral emboli, which could lead to cognitive impairment.Citation99

Cardiovascular risk factors

Not only is heart disease a risk factor for dementia, but more studies are implicating cardiovascular risk factors as both increasing the risk of dementia through risk of heart diseases and stroke,Citation100 and as independent risk factors for dementia.Citation101 Ettorre and colleagues reported that in a group of MCI patients, 60% of them eventually developed dementia, and all subgroups with cardiovascular risk factors had a higher conversion rate to AD.Citation102 In addition, many cardiovascular risk factors occur in conjunction with each other, compounding the risk of subtle gray matter changes and subclinical cerebrovascular abnormalities in the brain, as well as dementia.Citation103Citation106 When combined with the presence of the APOE ɛ4 allele and stroke, vascular risk factors lead to both vascular and AD pathology.Citation107,Citation108

Hypertension and hypotension

High blood pressure (BP) is a major risk factor for cerebrovascular disorders, including stroke, ischemic white matter lesions, and cerebral infarcts. It is well known that these disorders increase the risk of dementia.Citation64,Citation109,Citation110 Less known is that hypertension is an independent risk factor for dementia. The association between hypertension and risk of dementia is prominent, and while a rare study has failed to show this relationship,Citation111 the overwhelming majority show a positive association. The high prevalence of hypertension, especially between the age of 30 and 50 years, shows that insight into this relationship is important due to the potential it offers for prevention of cognitive impairment, as we discuss below.

Studies have shown that hypertension is associated with both VaD and AD.Citation112 In a review from the American Journal of Hypertension by Nagai and colleagues, out of seven cited studies, only one did not report that high systolic BP (SBP) and/or diastolic BP (DBP) were risk factors for dementia incidence.Citation113 Yamada and colleagues showed that elderly individuals with increased hypertension and SBP had increased risk of VaD.Citation114 The Cache County study by Mielke and colleagues further showed that SBP > 160 mmHg at baseline was associated with higher rates of cognitive decline in the elderly, compared with those with lower SBP. A study by Shah and colleagues showed a significant interaction between DBP and plasma Aβ levels, indicating that the Aβ-related risk for AD was higher when BP was higher.Citation115

Hypertension is also associated with an increased pulse pressure. In the Kungsholmen Project, patients aged ≥ 75 years with higher pulse pressure had a greater chance of developing dementia than controls. In comparison with the median tertile of pulse pressure (70–84 mmHg), those with higher pulse pressure had relative risk of 1.4 (95% CI 1.0–2.0; P = 0.04) for AD and 1.3 (95% CI 0.9–1.7) for dementia.Citation116 Midlife BP has been reported to have greater effect on the development of AD than late-life hypertension.Citation117

Different hypotheses have been offered to elucidate the pathophysiological links between hypertension and dementia. These include hypertension causing vascular alterations leading to lacunar and cortical infarcts and leukoaraiosis, hypertension being responsible for cerebrovascular disease, and hypertension leading to neurobiologic alterations, such as the accumulation of β-amyloid causing the onset of dementia. More specifically, hypertension may lead to hypoperfusion, or hypoxia of the brain, which can lead to AD pathology.Citation110,Citation118 Individuals who underwent antihypertensive treatment had lower neuritic plaques and neurofibrillary tangles than controls.Citation119 Hypertension also has an effect on the blood–brain barrier, leading to inflammation or the accumulation of β-amyloid, causing the development of AD. Brain imaging studies, such as the Honolulu-Asia Aging Study, reported that elevated levels of BP are associated with declines in gray matter volumes in the hippocampus and lateral temporal lobe.Citation120

Interestingly, hypotension has also been implicated in the development of dementia. Several longitudinal studies report that hypotension is a risk factor for dementia, but the studies are generally limited to the very elderly.Citation121 Most recently, in a study of 599 patients, Nilsson and colleagues reported that low SBP was associated with cognitive decline, dementia, and AD.Citation122

Diabetes mellitus

Diabetes is one of the strongest risk factors for dementia. Diabetes has also been associated with an increased prevalence of cognitive impairment.Citation24 In the Rotterdam study of 1999, diabetes mellitus was found to almost double the risk of dementia (relative risk [RR] 1.9 [1.3–2.8]) and AD (RR 1.9 [1.2–3.1]).Citation123 The Honolulu-Asia Aging study reinforced this association, showing that type 2 diabetes was associated with total dementia, AD, and VaD.Citation124 Another study from 2004 suggests that type 2 diabetes might be present in up to 80% of patients with AD.Citation125 A recent review by Beeri and colleagues reported an association between diabetes and risk of dementia and cognitive decline in most but not all epidemiological studies cited.Citation126 Brain imaging studies such as the CASCADE Study reported that diabetes is associated with cortical brain atrophy.Citation127 Much like other cardiovascular risk factors, the aggregation of diabetes and other risk factors leads to an acceleration in dementia risk. In this setting, the risk of AD is increased threefold.Citation16

There are several potential biological mechanisms underlying the association between diabetes mellitus and dementia including the impact of diabetes on cerebral microvessel dysfunction and oxidative stress.Citation128 In addition, the role of insulin itself may be important in the potential development of dementia and AD. Insulin degrading enzyme also degrades Aβ,Citation129 and in AD patients, insulin degrading enzyme levels are reduced,Citation130 which could contribute to the accumulation of Aβ in AD patients. Additionally, brain insulin signaling may be altered in AD, leading to pathological interactions between the receptor for advanced glycation end products and Aβ peptides.Citation131

Hypercholesterolemia, smoking, and obesity

The association between hypercholesterolemia and risk of dementia is still controversial. The accumulation of β-amyloid plaques and the loss of neurons, particularly in the hippocampus, are thought to be central events in the development of AD. Consequently, either overproduction or impaired clearance of β-amyloid, or both, may be causative in AD. It should be pointed out however that no direct causal relationship has been established between AD and the dysregulation of cholesterol metabolism. In particular, it is not clear whether the modification of cholesterol homeostasis in AD brains is a cause or a consequence of the disease.Citation132 For this reason, some have cautioned against inappropriate treatments.Citation133

There are a very limited number of studies on the association between smoking and risk of dementia. A recent meta-analysis of 19 prospective studies by Anstey and colleagues showed that smoking is a risk factor for cognitive decline and dementia.Citation134 More importantly smoking is a strong, independent risk factor for stroke,Citation135 which is a well established risk factor for dementia. A recent study reported that smoking showed the most consistent inverse association of all cardiovascular risk factors tested with cognitive test results.Citation136 As well, neuroimaging studies have associated smoking with reduced gray matter in the prefrontal cortex, anterior cingulate cortex, and temporal lobe in adults, and decreased frontal cortex, posterior cingulum, precuneus, and thalamus in the elderly.Citation137 Atrophy in these structures may contribute to the cognitive impairment.

Obesity is a growing problem in modern society and has been linked with the risk of dementia and cognitive impairment. Worldwide, low education is responsible for the largest contribution to dementia, but in the US, this is replaced by physical inactivity.Citation138 Body mass index (BMI) is associated with heart disease, in addition to its association with dementia. A recent cardiovascular health study reported that high BMI at midlife (obese, BMI > 30) is associated with higher dementia risk compared with normal weight individuals (HR 1.39, 95% CI 1.03–1.87).Citation139 These results are supported by previous studies by Kivipelto and colleagues and Whitmer and colleagues who also reported an association between midlife obesity and higher dementia risk.Citation140,Citation141 Diet is an important, and preventable, risk factor for the development of obesity and subsequently dementia. In particular, the consumption of a higher calorie diet rich in unsaturated fatty acids and cholesterol is associated with the development of AD and cognitive impairment through increased amyloidosis and altered synaptic plasticity.Citation142,Citation143

Treatment/prevention

Since the development of heart disease may be modifiable, the prevention of heart disease through the regulation and moderation of its risk factors is of the utmost importance.

Diet and exercise

A healthy diet is one modality for prevention of heart disease, but studies have shown very mixed results for diet as an effective method for slowing cognitive decline and dementia. A recent study by Vercambre and colleagues reported that an adherence to a Mediterranean-style diet was not associated with cognitive change in women at higher risk of cognitive decline due to vascular disease or risk factors.Citation144 Other studies testing the effects of omega-3 fatty acids, such as those found in dietary fish or fish oil, on cognitive decline found no effect of dietary doses of omega-3 fatty acids on the prevention of cognitive decline.Citation145,Citation146

Nevertheless, a healthy diet may indirectly reduce the likelihood of dementia. A prospective observational study of 36,019 subjects by Levitan and colleagues reported that those with diets consistent with the DASH (Dietary Approaches to Stop Hypertension) had a 37% lower rate of developing HF,Citation147 which has been shown previously to be a major risk factor for dementia. As well, multiple studies by Scarmeas and colleagues reported that more optimal adherence to the Mediterranean diet was associated with a reduced risk for AD as well as conversion to AD in MCI patients.Citation148Citation150 Salt reduction as recommended in the DASH diet is a major tool for reducing hypertension and its vascular consequences including dementia.

Exercise has been implicated in the prevention of cognitive decline and dementia. While studies on the exact relationship are still limited, a recent review by Román and colleagues highlights several studies showing physical activity and exercise as being strongly associated with improved cognition and a lower risk of cognitive decline.Citation151 A similar benefit of exercise in reducing AD risk has been reported.Citation152 Another systematic review by Aarsland and colleagues demonstrated a significant association between physical exercise and reduced risk of developing VaD.Citation153 Finally, a randomized controlled trial by Vreugdenhil and colleagues reported that AD patients who were in the exercise program had increased Mini-Mental State Examination scores and Instrumental Activities of Daily Living scores compared with those without exercise.Citation154

Treatment options

Since heart disease and cardiovascular risk factors have been associated with dementia, many studies have been conducted to determine whether there is a positive association between lowering such risk factors and lowering the risk of dementia. Antihypertensive medications have been tested extensively. Data from the Cache County Study demonstrated that the use of antihypertensives at baseline was associated with lower incidence of AD.Citation155 Also, a meta-analysis of randomized controlled trials by Feigin and colleagues supported the hypothesis that BP lowering may prevent dementia in those with vascular disease.Citation156 The cited studies include the Systolic Hypertension in Europe (Syst-Eur) trial, which showed that treating hypertension with an antihypertensive protocol, specifically the calcium channel blocker nitrendipine, resulted in a 50% reduction in incident cases of dementia.Citation157 A post-hoc analysis in the PROGRESS trial showed that dementia incidence in patients with recurring stroke was reduced by 34% when treated with antihypertensives.Citation158 The Kungsholmen Study reported that antihypertensive treatment was more effective in reducing dementia among those carrying the APOE ɛ4 allele.Citation159 These findings are consistent with those of the Honolulu-Asia Aging Study, which demonstrated that the association between high midlife BP and the development of AD was strongest among those who were never treated for hypertension.Citation160

Despite the growing number of positive studies, the Syst-Eur study remains the only recent study with a direct association between antihypertensive use and a decrease in the incidence of dementia.Citation161 The Hypertension in the very Elderly Trial Cognitive Function Assessment (HYVET-COG) study, which was a double-blind, placebo-controlled trial, reported that antihypertensive treatment in the elderly did not statistically reduce the incidence of dementia.Citation162 A meta-analysis of three randomized, double-blind, placebo controlled trials by McGuinness and colleagues reported that there was no convincing evidence from the trials that BP lowering in hypertensive patients prevented the development of dementia or cognitive impairment.Citation163 Despite these mixed results, the use of antihypertensive drugs for lowering midlife BP remains an important treatment option that may prevent the onset of dementia.

How far should BP be lowered? Studies by Lee and colleagues showed that BP in the range of SBP of 130–139 mmHg and DBP of 85–89 mmHg was associated with a substantial increase in stroke risk.Citation164 The SPS-3 trial should clarify this important issue, since prehypertension with SBP under 140 mmHg is frequently not treated aggressively.Citation165

Data for an association between statins and the prevention of AD neurodegeneration are mixed. Statins are used to lower cholesterol levels. A recent review highlights the controversial nature of statin use, reporting that statin users have a lower prevalence of AD, while also showing that there is no or only a modest decreased risk of AD.Citation166 Another review by Wolozin and colleagues confirms this finding.Citation167

Treatment of evident heart disease could also prove beneficial for the prevention of dementia. For example, Stanek and colleagues showed that when treated, HF patients improved their performance on cognitive tests.Citation168 Puccio and colleagues reported that AF patients treated with an anticoagulant, warfarin, showed better scores at the Clinical Dementia Rating Scale, the Geriatric Depression Scale, and the Global Deterioration Scale, suggesting a neuroprotective role.Citation169 Long-term warfarin is protective against the development of dementia in subjects with AF.Citation170

Another drug, donepezil, an acetylcholinesterase inhibitor, has shown promise as an anti-AD drug. In studies on mice, donepezil prevents cardiac rupture during the acute phase of MI through its inhibition of the enzymatic matrix metalloproteinase-9 (MMP-9), as well as through its prevention of pumping failure and cardiac remodeling.Citation171 Inhibiting the enzymatic activity of MMP-9 can be an effective treatment for AD.Citation172

In the Cardiovascular Health Study, Sink and colleagues reported that angiotensin converting enzyme (ACE) inhibitors might protect against dementia beyond control of BP. Centrally active ACE inhibitors that cross the blood–brain barrier were associated with 65% less decline on the mini-mental state exam when compared with other antihypertensive drugs.Citation173 In another study, the use of ACE inhibitors in HF patients was associated with an improvement in cognitive performance, and the probability of improvement increased with increasing dosage and longer treatment duration.Citation71

Conclusion

Heart disease as well as cardiovascular risk factors, particularly if they manifest in midlife, are associated with the eventual development of dementia later in life. Early prevention and treatment could potentially mitigate the onset of dementia. However, further research is still needed to find the most effective methods of dementia prevention and to better elucidate the vascular mechanisms of this disorder.

Disclosure

The authors report no conflicts of interest in this work.

References

  • FerriCPPrinceMBrayneCGlobal prevalence of dementia: a Delphi consensus studyLancet20053662112211716360788
  • United Nations, World Population Ageing 1950–2050, Population DivisionDESAUnited Nations, New York ST/ESA/SER.A/2072002
  • MathersCLeonardMGlobal burden of dementia in the year 2000: summary of methods and data sourcesGenevaWorld Health Organization2000
  • RitchieKLovestoneSThe dementiasLancet200236093471759176612480441
  • GanguliMSnitzBESaxtonJAOutcomes of mild cognitive impairment depend on definition: a population studyArch Neurol201168676176721670400
  • FleisherASSowellBBTaylorCGamstACPetersenRCThalLJClinical predictors of progression to Alzheimer disease in amnestic mild cognitive impairmentNeurology200768191588159517287448
  • HughesTFSnitzBEGanguliMShould mild cognitive impairment be subtyped?Current Opinion in Psychiatry201124323724221346570
  • WolozinBBednarMMInterventions for heart disease and their effects on Alzheimer’s diseaseNeurol Res20062863063616945215
  • PaglieriCBisbocciDCasertaMHypertension and cognitive functionClin Exp Hypertens200830870171019021021
  • WhitehousePJSciulliCGMasonRMDementia drug development: use of information systems to harmonize global drug developmentPsychopharmacol Bull19973311291339133764
  • RichardELigthartSAMoll van CharanteEPvan GoolWAVascular risk factors and dementia – towards prevention strategiesNeth J Med2010681028429021071773
  • DicksonDWThe pathogenesis of senile plaquesJ Neuropathol Exp Neurol1997563213399100663
  • IemoloFDuroGRizzoCPathophysiology of vascular dementiaImmun Ageing200961319895675
  • RomanGCVascular dementia: distinguishing characteristics, treatment, and preventionJ Am Geriatr Soc200351S296S30412801386
  • RosendorffCBeeriMSSilvermanJMCardiovascular risk factors for Alzheimer’s diseaseAm J Geriatr Cardiol20071614314917483665
  • LuchsingerJAReitzCHonigLSTangMXSheaSMayeuxRAggregation of vascular risk factors and risk of incident Alzheimer diseaseNeurology200565454555116116114
  • Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in AdultsExecutive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA20012852486249711368702
  • KwonHMKimBJLeeSHChoiSHOhBHYoonBWMetabolic syndrome as an independent risk factor of silent brain infarction in healthy peopleStroke200637246647016373631
  • YaffeKMetabolic syndrome and cognitive disorders: is the sum greater than its parts?Alzheimer Dis Assoc Disord20072116717117545744
  • LangaKMFosterNLLarsonEBMixed dementia: emerging concepts and therapeutic implicationsJAMA2004292232901290815598922
  • BowlerJHachinskiVVascular dementiaGinsbergMBogousslavskyJCerebrovascular Disease: Pathophysiology, Diagnosis, and ManagementOxford, UKScience Ltd199811261144
  • ReitzCBrickmanAMFrequency of subclinical heart disease in elderly persons with dementiaAm J Geriatr Cardiol200716318318817483671
  • JeffersonALHimaliJJBeiserASCardiac index is associated with brain aging: the Framingham Heart StudyCirculation2010122769069720679552
  • HallingABerglundJAssociation of diagnosis of ischaemic heart disease, diabetes mellitus and heart failure with cognitive function in the elderly populationEur J Gen Pract20061211411917002959
  • LaughlinGAMcEvoyLKvon MühlenDSex differences in the association of Framingham Cardiac Risk Score with cognitive decline in community-dwelling elders without clinical heart diseasePsychosom Med201173868368921949428
  • WolfPAContributions of the Framingham Heart Study to stroke and dementia epidemiologic research at 60 yearsArch Neurol201269556757122213410
  • WatanabeMTakedaTNakamagoeKTamaokaASequential imaging analysis using MIBG scintigraphy revealed progressive degeneration of cardiac sympathetic nerve in Parkinson’s diseaseEur J Neurol20111871010101321658161
  • NewmanAFitzpatrickALopezODementia and Alzheimer’s disease incidence in relationship to cardiovascular disease in the Cardiovascular Health Study cohortJ Am Geriatr Soc20055371101110716108925
  • RobertsROKnopmanDSGedaYEChaRHRogerVLPetersenRCCoronary heart disease is associated with non-amnestic mild cognitive impairmentNeurobiol Aging201031111894190219091445
  • RosengartTKSweetJFinninEBNeurocognitive functioning in patients undergoing coronary artery bypass graft surgery or perfuctaneous coronary intervention: evidence of impairment before intervention compared with normal controlsAnn Thorac Surg200580413271334 discussion1334133516181864
  • FreiheitEAHoganDBEliasziwMA dynamic view of depressive symptoms and neurocognitive change among patients with coronary artery diseaseArch Gen Psychiatry201269324425522393217
  • KoschackJIrleESmall hippocampal size in cognitively normal subjects with coronary artery diseaseNeurobiol Aging20052686587115718045
  • StellosKKatsikiNTatsidouPBigalkeBLaskeCAssociation of platelet activation with vascular cognitive impairment: implications in dementia development?Curr Vasc Pharmacol Epub1202012
  • SoneiraCFScottTMSevere cardiovascular disease and Alzheimer’s disease: senile plaque formation in cortical areasClin Anat199691181278720786
  • GrabanABednarska-MakarukMBochynskaALipczynska-LojkowskaWRyglewiczDWehrHVascular and biochemical risk factors of vascular dementia after lacunar strokes (S-VaD) and after multiinfarcts in strategic areas (M-VaD)J Neurol Sci20092831–211611819339023
  • VidalJSSigurdssonSJonsdottirMKCoronary artery calcium, brain function and structure: the AGES-Reykjavik StudyStroke20104189189720360538
  • RosanoCNaydeckBKullerLHCoronary artery calcium: associations with brain magnetic resonance imaging abnormalities and cognitive statusJ Am Geriatr Soc20055360961515817006
  • KovacicJCCastellanoJMFusterVThe links between complex coronary disease, cerebrovascular disease, and degenerative brain diseaseAnn N Y Acad Sci201212549910522548575
  • KovacicJCMorenoPNabelEGCellular senescence, vascular disease, and aging: part 2 of a 2-part review: clinical vascular disease in the elderlyCirculation20111231900191021537006
  • BellRDZlokovicBVNeurovascular mechanisms and blood–brain barrier disorder in Alzheimer’s diseaseActa Neuropathol200911810311319319544
  • ItohYYamadaMHayakawaMOtomoEMiyatakeTCerebral amyloid angiopathy: a significant cause of cerebellar as well as lobar cerebral hemorrhage in the elderlyJ Neurol Sci19931161351418336159
  • KwokCSLokeYKHaleRAtrial fibrillation and incidence of dementia: a systematic review and meta-analysisNeurology20117691492221383328
  • TamamBTaşdemirNTamamYThe prevalence of dementia three months after stroke and its risk factorsTurk Psikiyatri Derg20081914656 Turkish18330743
  • RastasSVerkkoniemiAPolvikoskiTAtrial fibrillation, stroke, and cognition: a longitudinal population-based study of people aged 85 and olderStroke2007381454146017395865
  • BarbaRMartinez-EspinosaSRodriguez-GarciaEPondalMVivancosJDel SerTPoststroke dementia: clinical features and risk factorsStroke2000311494150110884443
  • ZhouDHWangJYLiJDengJGaoCChenMStudy on frequency and predictors of dementia after ischemic stroke: The Chongging Stroke studyJ Neurol200425142142715083286
  • MariniCBaldassarreMRussoTA. Burden of first-ever ischemic stroke in the oldest old: evidence from a population-based studyNeurology200462778114718701
  • RatcliffePJWilcockGKCerebrovascular disease in dementia: the importance of atrial fibrillationPostgrad Med J1985617132012043983054
  • O’ConnellJEGrayCSFrenchJMAtrial fibrillation and cognitive function: case-control studyJ Neurol Neurosurg Psychiatry1998653863899728958
  • SabatiniTFrisoniGBBarbisoniPAtrial fibrillation and cognitive disorders in older peopleJ Am Geriatr Soc20004838739010798464
  • MielkeMMRosenbergPBTschanzJVascular factors predict rate of progression in Alzheimer diseaseNeurology2007691850185817984453
  • BunchTJWeissJPCrandallBGAtrial fibrillation is independently associated with senile, vascular, and Alzheimer’s dementiaHeart Rhythm2010743343720122875
  • OttABretelerMMde BruyneMCvanHFGrobbeeDEHofmanAAtrial fibrillation and dementia in a population-based study. The Rotterdam StudyStroke19972823163219040682
  • MarzonaIO’DonnellMTeoKIncreased risk of cognitive and functional decline in patient with atrial fibrillation: results of the ONTARGET and TRANSCEND studiesCMAJ20121846E329E33622371515
  • MiyasakaYBarnesMEPetersenRCRisk of dementia in stroke-free patients diagnosed with atrial fibrillation: data from a community-based cohortEur Heart J2007281962196717459900
  • Wozakowska-KapłonBOpolskiGKosiorDJaskulska-NiedzielaEMaroszyńska-DmochEWłosowiczMCognitive disorders in elderly patients with permanent atrial fibrillationKardiol Pol20096748749319521933
  • KnechtSOelschlagerCDuningTAtrial fibrillation in stroke free patients is associated with memory impairment and hippocampal atrophyEur Heart J2008292125213218667399
  • Kermode-ScottBAtrial fibrillation increases the risk of cognitive decline and need for long term careBMJ2012344e159122381705
  • SchraderJThe significance of arterial hypertension for the development of dementiaMMW Fortschr Med200414647404215624656
  • PetersenPKastrupJVidebaekRBoysenGCerebral blood flowbefore and after cardioversion of atrial fibrillationJ Cereb Blood Flow Metab198994224252715212
  • DuronEHanonOAtrial fibrillation and cognitive functionPsychol. Neuropsychiatr Vieil2010820921420739259
  • MorrisonTBBunchTJGershBJPathophysiology of concomitant atrial fibrillation and heart failure: implications for managementNat Clin Pract Cardiovasc Med20096465619047993
  • EzekowitzMDJamesKENazarianSMVeterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation InvestigatorsSilent cerebral infarction in patients with nonrheumatic atrial fibrillationCirculation1995928217821827554199
  • VermeerSEPrinsNDden HeijerTHofmanAKoudstaalPJBretelerMMSilent brain infarcts and the risk of dementia and cognitive declineN Engl J Med20033481215122212660385
  • ZitoMMuscariAMariniEDi IorioAPudduGMAbateGSilent lacunar infarcts in elderly patients with chronic non valvular atrial fibrillationAging (Milano)199683413468959236
  • ChoudhuryALipGYAtrial fibrillation and the hypercoagulable state: from basic science to clinical practicePathophysiol Haemost Thromb20033328228915692230
  • BarberMTaitRCScottJRumleyALoweGDStottDJDementia in subjects with atrial fibrillation: hemostatic function and the role of anticoagulationJ Thromb Haemost200421873187815550013
  • KalariaRNThe role of cerebral ischemia in Alzheimer’s diseaseNeurobiol Aging20002132133010867217
  • LongstrethWTJrManolioTAArnoldAClinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people: the Cardiovascular Health StudyStroke199627127412828711786
  • IkramMAHollanderMBosMJUnrecognized myocardial infarction and the risk of stroke: the Rotterdam StudyNeurology2006671635163917101896
  • ZuccalaGOnderGPedoneCHypotension and cognitive impairment: selective association in patients with heart failureNeurology2001571986199211739814
  • BretelerMMClausJJGrobbeeDECardiovascular disease and distribution of cognitive function in elderly people: the Rotterdam StudyBMJ1994308160416088025427
  • AronsonMKOoiWLMorgensternHWomen, myocardial infarction, and dementia in the very oldNeurology199040110211062356012
  • GharacholouSMReidKJArnoldSVCognitive impairment and outcomes in older adult survivors of acute myocardial infarction: findings from the translational research investigating underlying disparities in acute myocardial infarction patients’ health status registryAm Heart J2011162586086922093202
  • IkramMAOijenMJongFJUnrecognized myocardial infarction in relation to risk of dementia and cerebral small vessel diseaseStroke20083951421142618323497
  • GrubbNRSimpsonCFoxKAMemory function in patients with stable, moderate to severe cardiac failureAm Heart J20001401510874250
  • PetrovitchHWhiteLMasakiKHInfluence of myocardial infarction, coronary artery bypass surgery, and stroke on cognitive impairment in late lifeAm J Cardiol199881101710219576163
  • BursiFRoccaWAKillianJMHeart disease and dementia: a population-based studyAm J Epidemiol200616313514116293716
  • CorderEErvinJFLockhartESzymanskiMHSchmechelDEHuletteCMCardiovascular damage in Alzheimer disease: autopsy findings from the Bryan ADRCJ Biomed Biotechnol20052005218919716046825
  • BoudoulasKDSparksEARittgersSEWooleyCFBoudoulasHFactors determining left atrial kinetic energy in patients with chronic mitral valve diseaseHerz20032843744412928743
  • RodriguezCJBartzTMLonstrethWTJrAssociation of annular calcification and aortic valve sclerosis with brain findings on magnetic resonance imaging in community dwelling older adults: the cardiovascular health studyJ Am Coll Cardiol201157212172218021596233
  • Oliveira-FilhoJMassaroARYamamotoFBustamanteLScaffMStroke as the first manifestation of calcific aortic stenosisCerebrovasc Dis20001041341610971029
  • de la TorreJCCardiovascular risk factors promote brain hypoperfusion leading to cognitive decline and dementiaCardiovasc Psychiatry Neurol2012201236751623243502
  • BelohlavekMJiamsripongPCallejaAMPatients with Alzheimer disease have altered transmitral flow: echocardiographic analysis of the vortex formation timeJ Ultrasound Med20091128111493150019854964
  • GiamouzisGTriposkiadisFButlerJWestermannDGiannakoulasGHeart failureCardiol Res Pract2011201115960821738853
  • AlmeidaOPBeerCLautenschlagerNTArnoldaLAlfonsoHFlickerLTwo-year course of cognitive function and mood in adults with congestive heart failure and coronary artery disease: the Heart-Mind StudyInt Psychogeriatr2012241384722093251
  • TrojanoLIncalziRAAcanforaDPiconeCMecocciPRengoFCognitive impairment: a key feature of congestive heart failure in the elderlyJ Neurol2003250121456146314673579
  • VogelsRLCWeinsteinHCSchroeder-TankaJMCognitive impairment in heart failure: a systematic review of literatureEur J Heart Fail2006513334
  • LaveryLVander BiltJChangCCSaxtonJAGanguliMThe association between congestive heart failure and cognitive performance in a primary care population of elderly adults: the Steel Valley Seniors SurveyInt Psychogeriatr2007221522516684398
  • SauveMJLewisWRBlankenbillerMRickabaughBPresslerSJCognitive impairments in chronic heart failure: a case controlled studyJ Card Fail20091511019181287
  • QiuCWinbladBMarengoniAKlarinIFastbomJFratiglioniLHeart failure and risk of dementia and Alzheimer disease: a population-based cohort studyArch Intern Med200616691003100816682574
  • PolidoriCMMarianiEMecocciPCongestive heart failure and Alzheimer’s diseaseNeurol Res200628658859416945209
  • BeerCEbenezerEFennerSContributors to cognitive impairment in congestive heart failure: a pilot case-control studyIntern Med J200939960060519220544
  • AlvesTCRaysJFraguasRJrLocalized cerebral blood flow reductions in patients with heart failure: a study using 99mTc- HMPAO SPECTJ Neuroimaging20051515015615746227
  • LoncarGBozicBLepicTRelationship of reduced cerebral blood flow and heart failure severity in elderly malesAging Male2011141596520873985
  • GruhnNLarsenFSBoesgaardSCerebral blood flow in patients with chronic heart failure before and after heart transplantationStroke200132112530253311692012
  • JeffersonALPoppasAPaulRHCohenRASystemic hypoperfusion is associated with executive dysfunction in geriatric cardiac patientsNeurobiol Aging200728347748316469418
  • TriposkiadisFKarayannisGGiamouzisGSkoularigisJLouridasGButlerJThe sympathetic nervous system in heart failure. Physiology, pathophysiology, and clinical implicationsJ Am Coll Cardiol200954191747176219874988
  • PullicinoPMHartJCognitive impairment in congestive heart failure? Embolism vs hypoperfusionNeurology200157111945194611739807
  • ShprakhVVSuvorovaIAPost-stroke vascular dementia: risk factors and clinical neuro-imaging featuresAdv Gerontol201023229330021033386
  • AlonsoAMosleyTHJrGottesmanRFRisk of dementia hospitalization associated with cardiovascular risk factors in midlife and older age: the Atherosclerosis Risk in Communities (ARIC) studyJ Neurol Neurosurg Psychiatry2009801194120119692426
  • EttorreECerraEMariglianoBRole of cardiovascular risk factors (CRF) in the patients with mild cognitive impairment (MCI)Arch Gerontol Geriatr201254233033221632127
  • de Toledo Ferraz AlvesTCScazufcaMSquarzoniPSubtle gray matter changes in temporo-parietal cortex associated witho cardiovascular risk factorsJournal of Alzheimer’s Disease201127575589
  • SchwartzEWicinskiBSchmeidlerJHaroutunianVHofPRCardiovascular risk factors affect hippocampal microvasculature in early ADTransl Neurosci20101429229921331351
  • SkoogIGustafsonDUpdate on hypertension and Alzheimer’s diseaseNeurol Res200628660561116945211
  • WeinerMRosenbergRWomackKAtherosclerosis risk factors in American Indians with Alzheimer’s disease: preliminary findingsAlzheimer Dis Assoc Disord200822324524818580594
  • MielkeMMLeoutsakosJ-MTschanzJTInteraction between vascular factors and the APOE ɛ4 allele in predicting rate of progression in Alzheimer’s diseaseJ Alzheimers Dis201126112713421593560
  • JinYPOstbyeTFeightnerJWDi LeggeSHachinskiVJoint effect of stroke and APOE 4 on dementia risk: the Canadian Study of Health and AgingNeurology20087091617978275
  • CelleSAnnweilerCPichotVAssociation between ambulatory 24-hour blood pressure levels and brain volume reduction: a cross-sectional elderly population-based studyHypertension20126051324133123045461
  • de la TorreJCCritically attained threshold of cerebral hypoperfusion: the CATCH hypothesis of Alzheimer’s pathogenesisNeurobiol Aging20002133134210867218
  • JohnsonKCMargolisKLEspelandMAA prospective study of the effect of hypertension and baseline blood pressure on cognitive decline and dementia in postmenopausal women: the Women’s Health Initiative Memory StudyJ Am Geriatr Soc20085681449145818637980
  • StaessenJARichartTBirkenhagerWHLess atherosclerosis and lower blood pressure for a meaningful life perspective with more brainHypertension20074938940017283254
  • NagaiMHoshideSKarioKHypertension and dementiaAm J Hypertens20102311612419927134
  • YamadaMKasagiFSasakiHMasunariNMimoriYSuzukiGAssociation between dementia and midlife risk factors: the Radiation Effects Research Foundation Adult Health StudyJ Am Geriatr Soc20035141041412588587
  • ShahNSVidalJ-SMasakiKMidlife blood pressure, plasma β-amyloid, and the risk for Alzheimer disease: The Honolulu Asia Aging StudyHypertension201259478078622392902
  • FranklinSSKhanSAWongNDLarsonMGLevyDIs pulse pressure useful in predicting risk for coronary heart disease? The Framingham Heart StudyCirculation199910035436010421594
  • QiuCWinbladBFratiglioniLThe age-dependent relation of blood pressure to cognitive function and dementiaLancet Neurol2005448749916033691
  • KalbackWEshCCastañoEMAtherosclerosis, vascular amyloidosis and brain hypoperfusion in the pathogenesis of sporadic Alzheimer’s diseaseNeurol Res20042652553915265270
  • HoffmanLBSchmeidlerJLesserGTLess Alzheimer disease neuropathology in medicated hypertensive than nonhypertensive personsNeurology200972201720172619228583
  • de Toledo Ferraz AlvesTCFerreiraLKWajngartenMBusattoGFCardiac disorders as risk factors for Alzheimer’s diseaseJ Alzheimers Dis201020374976320413875
  • KennellySPLawlorBAKennyRABlood pressure and the risk for dementia-A double edged swordAgeing Res Rev200982617019063999
  • NilssonSEReadSBergSJohanssonBMelanderALindbladULow systolic blood pressure is associated with impaired cognitive function in the oldest old: longitudinal observations in a population-based sample 80 years and olderAging Clin Exp Res200719414717332720
  • OttAStolkRPvan HarskampFPolsHAHofmanABretelerMMDiabetes mellitus and the risk of dementia: the Rotterdam StudyNeurology19995391937194210599761
  • PeilaRRodriguezBLLaunerLJType 2 diabetes, APOE gene, and the risk for dementia and related pathologies: the Honolulu-Asia Aging StudyDiabetes20025141256126211916953
  • JansonJLaedtkeTParisiJEO’BrienPPetersenRCButlerPCIncreased risk of type 2 diabetes in Alzheimer diseaseDiabetes200453247448114747300
  • BeeriMSRavona-SpringerRSilvermanJMHaroutunianVThe effects of cardiovascular risk factors on cognitive compromiseDialogues Clin Neurosci20091120121219585955
  • SchmidtRLaunerLJNilssonLGCASCADE Consortium Magnetic resonance imaging of the brain in diabetes: the Cardiovascular Determinants of Dementia (CASCADE) StudyDiabetes200453368769214988253
  • SkoogIGustafsonDHypertension, hypertension-clustering factors and Alzheimer’s diseaseNeurol Res200325667568014503023
  • FarrisWMansourianSChangYInsulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivoProc Natl Acad Sci USA200310074162416712634421
  • QiuWQFolsteinMFInsulin, insulin-degrading enzyme and amyloid-β peptide in Alzheimer’s disease: review and hypothesisNeurobiol Aging200627219019816399206
  • TakedaSSatoNRakugiHMorishitaRMolecular mechanisms linking diabetes mellitus and Alzheimer disease: beta-amyloid peptide, insulin signaling, and neuronal functionMol Biosyst2011761822182721431241
  • VanceJEDysregulation of cholesterol balance in the brain: contribution to neurodegenerative diseasesDis Model Mech20125674675523065638
  • RoblesBayòn AGudeSampedro FInappropriate treatments for patients with cognitive declineNeurologia2012S0213-485312001855
  • AnsteyKJvon SandenCSalimAO’KearneyRSmoking as a risk factor for dementia and cognitive decline: a meta-analysis of prospective studiesAm J Epidemiol200716636737817573335
  • KellyTNGuDChenJCigarette smoking and risk of stroke in the Chinese adult populationStroke2008391688169318323480
  • ArntzenKASchirmerHWilsgaardTMathiesenEBImpact of cardiovascular risk factors on cognitive function: the Tromsø studyEur J Neurol20111873774321143340
  • de Toledo Ferraz AlvesTCFerreiraLKBusattoGFVascular diseases and old age mental disorders: an update of neuroimaging findingsCurr Opin Psychiatry201023649149720733494
  • BarnesDEYaffeKThe projected effect of risk factor reduction on Alzheimer’s disease prevalenceLancet Neurol201110981982821775213
  • FitzpatrickALKullerLHLopezOLMidlife and late-life obesity and the risk of dementia: cardiovascular health studyArch Neurol20096633634219273752
  • KivipeltoMNganduTFratiglioniLObesity and vascular risk factors at midlife and the risk of dementia and Alzheimer diseaseArch Neurol200562101556156016216938
  • WhitmerRAGundersonEPBarrett-ConnorEQuesenberryCPJrYaffeKObesity in middle age and future risk of dementia: a 27 year longitudinal population based studyBMJ20053307504136015863436
  • MartinsIJHoneEFosterJKApolipoprotein E, cholesterol metabolism, diabetes, and the convergence of risk factors for Alzheimer’s disease and cardiovascular diseaseMol Psychiatry200611872173616786033
  • PasinettiGMEbersteinJAMetabolic syndrome and the role of dietary lifestyles in Alzheimer’s diseaseJ Neurochem20081061503151418466323
  • VercambreM-NGrodsteinFBerrCKangJHMediterranean diet and cognitive decline in women with cardiovascular disease or risk factorsJ Acad Nutr Diet2012112681682322709809
  • Freund-LeviYEriksdotter-JonhagenMCederholmTOmega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trialArch Neurol200663101402140817030655
  • GeleijnseJMGiltayEJKromhoutDEffects of N-3 fatty acids on cognitive decline: a randomized, double-blind, placebo-controlled trial in stable myocardial infarction patientsAlzheimers Dement20128427828721967845
  • LevitanEBWolkAMittlemanMAConsistency with the DASH diet and incidence of heart failureArch Intern Med2009169985185719433696
  • ScarmeasNSternYTangMXMayeuxRLuchsingerJAMediterranean diet and mild cognitive impairmentArch Neurol20096621622519204158
  • ScarmeasNSternYTangMXMayeuxRLuchsingerJAMediterranean diet and risk for Alzheimer’s diseaseAnn Neurol200659691292116622828
  • ScarmeasNSternYMayeuxRLuchsingerJAMediterranean diet, Alzheimer disease, and vascular mediationArch Neuro2006631217091717
  • RománGCNashDTFillitHTranslating current knowledge into dementia preventionAlzheimer Dis Assoc Disord201226429529922710935
  • LarsonEBWangLBowenJDExercise is associated with reduced risk for incident dementia among persons 65 years of age and olderAnnal Intern Med200614427381
  • AarslandDSardahaeeFSAnderssenSBallardCIs physical activity a potential preventive factor for vascular dementia? A systematic reviewAging Ment Health20101438639520455113
  • VreugdenhilACannellJDaviesARazayGA community-based exercise programme to improve functional ability in people with Alzheimer’s disease: a randomized controlled trialScand J Caring Sci2012261121921564154
  • KhachaturianASZandiPPLyketsosCGAntihypertensive medication use and incident Alzheimer disease: the Cache County StudyArch Neurol200663568669216533956
  • FeiginVRatnasabapathyYAndersonCDoes blood pressure lowering treatment prevents dementia or cognitive decline in patients with cardiovascular and cerebrovascular disease?J Neurol Sci2005229230151155
  • ForetteFSeuxMLStaessenJAThe prevention of dementia with antihypertensive treatment: new evidence from the Systolic Hypertension in Europe (Syst-Eur) studyArch Intern Med20021622046205212374512
  • TzourioCAndersonCChapmanNEffects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular diseaseArch Intern Med20031631069107512742805
  • GuoZFratiglioniLViitanenMApolipoprotein E genotypes and the incidence of Alzheimer’s disease among persons aged 75 years and older: variation by use of antihypertensive medication?Am J Epidemiol200115322523111157409
  • LaunerLJRossGWPetrovitchHMidlife vascular risk factors and Alzheimer’s disease in later life: longitudinal, population based studyBrit Med J20013221447145111408299
  • IgaseMKoharaKMikiTThe Association between Hypertension and Dementia in the ElderlyInt J Hypertens2012201232064822121477
  • PetersRBeckettNForetteFIncident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trialLancet Neurol20087868368918614402
  • McGuinnessBToddSPassmorePBullockRThe effects of blood pressure lowering on development of cognitive impairment and dementia in patients without apparent prior cerebrovascular diseaseCochrane Database Syst Rev20062CD00403416625595
  • LeeMSaverJLChangBChangKHHaoQOvbiageleBPresence of baseline prehypertension and risk of incident stroke: a meta-analysisNeurology201177141330133721956722
  • BenaventeORWhiteCLPearceLThe Secondary Prevention of Small Subcortical Strokes (SPS3) studyInt J Stroke20116216417521371282
  • QiuCKivipeltoMvon StraussEEpidemiology of Alzheimer’s disease: occurrence, determinants, and strategies toward interventionDialogues Clin Neurosci200911211112819585947
  • WolozinBBednarMMInterventions for heart disease and their effects on Alzheimer’s diseaseNeurol Res20062863063616945215
  • StanekKMGunstadJPaulRHLongitudinal cognitive performance in older adults with cardiovascular disease: evidence for improvement in heart failureJ Cardiovasc Nurs200924319219719390336
  • PuccioDNovoGBaiamonteVAtrial fibrillation and mild cognitive impairment: what correlation?Minerva Cardioangiol20095714315019274024
  • BarberMTaitRCScottJRumleyALoweGDStottDJDementia in subjects with atrial fibrillation: hemostatic function and the role of anticoagulationJ Thromb Haemost20042111873187815550013
  • ArikawaMKakinumaYHandaTYamasakiFSatoTDonepezil, anti-Alzheimer’s disease drug, prevents cardiac rupture during acute phase of myocardial infarction in micePLoS One201167e2062921750701
  • HandaTKatareRGKakinumaYAnti-Alzheimer’s drug, Donepezil, markedly improves long-term survival after chronic heart failure in miceJ Card Fail200915980581119879468
  • SinkKMLengXWilliamsonJAngiotensin-converting enzyme inhibitors and cognitive decline in older adults with hypertension: results from the Cardiovascular Health StudyArch Intern Med2009169131195120219597068